Yi Zhou

Yi Zhou is the founder of Agentic Engineering, the AI-native engineering discipline for building production-grade enterprise AI systems. An award-winning Chief AI Officer and globally recognized AI leader, he has led more than 600 enterprise AI deployments across regulated and mission-critical industries, generating over $1 billion in realized value.

Yi pioneered several industry-defining AI platforms and breakthroughs across healthcare, life sciences, and enterprise technology. His innovations include 12 FDA-cleared AI medical imaging devices across X-ray, CT, and MRI, the Immune Medicine Platform used by more than 170 biopharma companies, the Edison AI Platform, the Human Genome Analytics Platform, and AI-powered athlete performance systems for the Olympic Games. These innovations earned numerous industry honors, including two Seattle CIO of the Year ORBIE Awards, two Fortune 500 CEO Awards, and three DNA Innovation Awards.

Yi is one of the leading voices shaping the future of enterprise AI and AI governance. He is the lead author of the Agentic Engineering Body of Practices (AEBOP) standard and the GE AI Standards, author of three books and more than 70 publications on enterprise AI, and an advisor to global regulators including the FDA and EMA on AI governance frameworks.